Aspirin use and endometrial cancer risk: a meta-analysis and systematic review
Author(s) -
Yang Wang,
Junda Zhao,
Xing Chen,
Feifei Zhang,
Xin Li
Publication year - 2020
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2020.03.125
Subject(s) - medicine , aspirin , endometrial cancer , odds ratio , relative risk , subgroup analysis , confidence interval , cohort study , meta analysis , cohort , oncology , randomized controlled trial , case control study , cancer , gynecology
Our results suggest that the use of aspirin was associated with a reduced risk of endometrial cancer, and the reduced risk was closely related to the high-frequency of use. Further randomized controlled trials (RCTs) are needed to confirm these findings.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom